{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:50:44Z","timestamp":1791287444527,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1132800"],"award-info":[{"award-number":["OPP1132800"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cryptosporidiosis, an enteric protozoon, causes substantial morbidity and mortality associated with diarrhea in children &amp;lt;2 years old in low- to middle-income countries. There is no vaccine and treatments are inadequate. A piperazine-based compound, MMV665917, has in vitro and in vivo efficacy against Cryptosporidium parvum. In this study, we evaluated the efficacy of MMV665917 in gnotobiotic piglets experimentally infected with Cryptosporidium hominis, the species responsible for &amp;gt;75% of diarrhea reported in these children.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Gnotobiotic piglets were orally challenged with C hominis oocysts, and oral treatment with MMV665917 was commenced 3 days after challenge. Oocyst excretion and diarrhea severity were observed daily, and mucosal colonization and lesions were recorded after necropsy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>MMV665917 significantly reduced fecal oocyst excretion, parasite colonization and damage to the intestinal mucosa, and peak diarrheal symptoms, compared with infected untreated controls. A dose of 20 mg\/kg twice daily for 7 days was more effective than 10 mg\/kg. There were no signs of organ toxicity at either dose, but 20 mg\/kg was associated with slightly elevated blood cholesterol and monocytes at euthanasia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results demonstrate the effectiveness of this drug against C hominis. Piperazine-derivative MMV665917 may potentially be used to treat human cryptosporidiosis; however, further investigations are required.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiz105","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T12:17:04Z","timestamp":1552997824000},"page":"285-293","source":"Crossref","is-referenced-by-count":30,"title":["Piperazine-Derivative MMV665917: An Effective Drug in the Diarrheic Piglet Model of Cryptosporidium hominis"],"prefix":"10.1093","volume":"220","author":[{"given":"Sangun","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ginese","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Girouard","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Beamer","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D","family":"Huston","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Vermont Larner College of Medicine, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon","family":"Osbourn","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Griggs","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Tzipori","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"2020071805362804300_CIT0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"2020071805362804300_CIT0002","doi-asserted-by":"crossref","first-page":"e0004729","DOI":"10.1371\/journal.pntd.0004729","article-title":"The burden of Cryptosporidium diarrheal disease among children &lt; 24 months of age in moderate\/high mortality regions of sub-Saharan Africa and South Asia, utilizing data from the Global Enteric Multicenter Study (GEMS)","volume":"10","author":"Sow","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2020071805362804300_CIT0003","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijpara.2017.08.001","article-title":"Innate immune responses play a key role in controlling infection of the intestinal epithelium by Cryptosporidium","volume":"47","author":"Laurent","year":"2017","journal-title":"Int J Parasitol"},{"key":"2020071805362804300_CIT0004","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004932.pub2","article-title":"Prevention and treatment of cryptosporidiosis in immunocompromised patients","author":"Abubakar","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2020071805362804300_CIT0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1399-3046.2006.00593.x","article-title":"Severe cryptosporidiosis in a seven-year-old renal transplant recipient: case report and review of the literature","volume":"11","author":"Hong","year":"2007","journal-title":"Pediatr Transplant"},{"key":"2020071805362804300_CIT0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exppara.2009.07.005","article-title":"Cryptosporidium and Giardia: treatment options and prospects for new drugs","volume":"124","author":"Rossignol","year":"2010","journal-title":"Exp Parasitol"},{"key":"2020071805362804300_CIT0007","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2125.2007.02873.x","article-title":"Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis","volume":"63","author":"Abubakar","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"2020071805362804300_CIT0008","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","article-title":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial","volume":"360","author":"Amadi","year":"2002","journal-title":"Lancet"},{"key":"2020071805362804300_CIT0009","doi-asserted-by":"crossref","first-page":"e1005763","DOI":"10.1371\/journal.ppat.1005763","article-title":"Open source drug discovery with the malaria box compound collection for neglected diseases and beyond","volume":"12","author":"Van Voorhis","year":"2016","journal-title":"PLoS Pathog"},{"key":"2020071805362804300_CIT0010","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/AAC.02641-13","article-title":"Identification of Cryptosporidium parvum active chemical series by repurposing the open access malaria box","volume":"58","author":"Bessoff","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2020071805362804300_CIT0011","article-title":"A novel piperazine-based drug lead","volume":"62:e01505\u201317","author":"Jumani","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020071805362804300_CIT0012","doi-asserted-by":"crossref","first-page":"e0006183","DOI":"10.1371\/journal.pntd.0006183","article-title":"Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model","volume":"12","author":"Stebbins","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2020071805362804300_CIT0013","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00147-18","article-title":"Therapeutic efficacy of bumped kinase inhibitor 1369","author":"Lee","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020071805362804300_CIT0014","doi-asserted-by":"crossref","first-page":"e0185906","DOI":"10.1371\/journal.pone.0185906","article-title":"The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"2020071805362804300_CIT0015","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1128\/IAI.70.10.5670-5675.2002","article-title":"Genetic analysis of a Cryptosporidium parvum human genotype 1 isolate passaged through different host species","volume":"70","author":"Akiyoshi","year":"2002","journal-title":"Infect Immun"},{"key":"2020071805362804300_CIT0016","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4269\/ajtmh.2006.75.851","article-title":"Cryptosporidium hominis: experimental challenge of healthy adults","volume":"75","author":"Chappell","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"2020071805362804300_CIT0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpara.2015.07.006","article-title":"Continuous culture of Cryptosporidium parvum using hollow fiber technology","volume":"46","author":"Morada","year":"2016","journal-title":"Int J Parasitol"},{"key":"2020071805362804300_CIT0018","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CDLI.1.4.450-463.1994","article-title":"Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin","volume":"1","author":"Tzipori","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"2020071805362804300_CIT0019","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","article-title":"Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)","volume":"3","author":"Platts-Mills","year":"2015","journal-title":"Lancet Glob Health"},{"key":"2020071805362804300_CIT0020","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.fct.2007.07.011","article-title":"Safety assessment of hydroxypropyl methylcellulose as a food ingredient","volume":"45","author":"Burdock","year":"2007","journal-title":"Food Chem Toxicol"},{"key":"2020071805362804300_CIT0021","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jn\/138.2.292","article-title":"Hydroxypropylmethylcellulose and methylcellulose consumption reduce postprandial insulinemia in overweight and obese men and women","volume":"138","author":"Maki","year":"2008","journal-title":"J Nutr"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/2\/285\/33510608\/jiz105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/2\/285\/33510608\/jiz105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T09:36:39Z","timestamp":1595064999000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/220\/2\/285\/5407888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,3,20]]},"published-print":{"date-parts":[[2019,6,19]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz105","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7,15]]},"published":{"date-parts":[[2019,3,20]]}}}